5-Minute Check In: Genetic Therapies for Sickle Cell Disease Artwork

5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn

Hosted by Dr. Thomas McGinn, Professor, Baylor College of Medicine; Clinical Professor of Medicine at Creighton University School of Medicine; Senior Executive Vice President and Chief Physician Executive Officer, CommonSpirit Health Physician Enterprise. Dr. McGinn brings the latest healthcare news to physicians and advanced practice providers.

All Episodes

5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn

5-Minute Check In: Genetic Therapies for Sickle Cell Disease

January 18, 2024 • CommonSpirit Health Physician Enterprise • Season 3 • Episode 2

The FDA has approved the first cell-based gene therapies for sickle cell disease. In this extended episode, Dr. McGinn is joined by Creighton Geneticist and Bioethicist Fr. Kevin FitzGerald and Dr. Ankita Sagar, System Vice President for Clinical Standards and Variation Reduction, to dive into this significant milestone.

Together they discuss CRISPR technology, treatment strategies, bioethics, and what this means for patients and providers alike in our battle against this devastating disease.

Read more: https://www.fda.gov/news-events/press...